Covid-19: Sanofi and GSK to seek regulatory authorisation for protein based vaccine Post date 28 February 2022 ← Covid-19: Incomplete lists of vulnerable patients left many unprotected, desperate, and afraid → Covid-19: CDC relaxes rules on mask wearing